FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

9328611000001106: Fluticasone propionate 50micrograms/dose nasal spray (Kent Pharma (UK) Ltd) 150 dose (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1883661000001119 Fluticasone propionate 50micrograms/dose nasal spray (Kent Pharma (UK) Ltd) 150 dose en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1883671000001112 Fluticasone propionate 50micrograms/dose nasal spray (Kent Pharma (UK) Ltd) 150 dose (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Fluticasone propionate 50micrograms/dose nasal spray (Kent Pharma (UK) Ltd) 150 dose Is a Fluticasone 50micrograms/actuation nasal spray 150 dose true Inferred relationship Existential restriction modifier
Fluticasone propionate 50micrograms/dose nasal spray (Kent Pharma (UK) Ltd) 150 dose Is pack of Fluticasone propionate 50micrograms/dose nasal spray (Kent Pharma (UK) Ltd) false Inferred relationship Existential restriction modifier
Fluticasone propionate 50micrograms/dose nasal spray (Kent Pharma (UK) Ltd) 150 dose Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Fluticasone propionate 50micrograms/dose nasal spray (Kent Pharma (UK) Ltd) 150 dose Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Fluticasone propionate 50micrograms/dose nasal spray (Kent Pharma (UK) Ltd) 150 dose Has active ingredient Fluticasone propionate false Inferred relationship Existential restriction modifier
Fluticasone propionate 50micrograms/dose nasal spray (Kent Pharma (UK) Ltd) 150 dose Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Fluticasone propionate 50micrograms/dose nasal spray (Kent Pharma (UK) Ltd) 150 dose Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Fluticasone propionate 50micrograms/dose nasal spray (Kent Pharma (UK) Ltd) 150 dose Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Fluticasone propionate 50micrograms/dose nasal spray (Kent Pharma (UK) Ltd) 150 dose VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Fluticasone propionate 50micrograms/dose nasal spray (Kent Pharma (UK) Ltd) 150 dose VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Fluticasone propionate 50micrograms/dose nasal spray (Kent Pharma (UK) Ltd) 150 dose Has manufactured dose form Spray dose form false Inferred relationship Existential restriction modifier
Fluticasone propionate 50micrograms/dose nasal spray (Kent Pharma (UK) Ltd) 150 dose Has AMP Fluticasone propionate 50micrograms/dose nasal spray (Kent Pharma (UK) Ltd) true Inferred relationship Existential restriction modifier
Fluticasone propionate 50micrograms/dose nasal spray (Kent Pharma (UK) Ltd) 150 dose Has specific active ingredient Fluticasone propionate true Inferred relationship Existential restriction modifier
Fluticasone propionate 50micrograms/dose nasal spray (Kent Pharma (UK) Ltd) 150 dose Has dispensed dose form Spray dose form true Inferred relationship Existential restriction modifier
Fluticasone propionate 50micrograms/dose nasal spray (Kent Pharma (UK) Ltd) 150 dose Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Fluticasone propionate 50micrograms/dose nasal spray (Kent Pharma (UK) Ltd) 150 dose Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start